Evidence map›Paper›PMID 36297586›Full record

ArticlePharmaceutics2022

Topographical and Compositional Gradient Tubular Scaffold for Bone to Tendon Interface Regeneration.

Eleonora Bianchi, Angela Faccendini, Elena Del Favero, Caterina Ricci, Laura Caliogna, Barbara Vigani, Francesco Claudio Pavesi, Cesare Perotti, Rui M A Domingues, Manuela E Gomes and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Anatomical Tissue Engineering of the Anterior Cruciate Ligament Entheses.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Eleonora BianchiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Angela FaccendiniDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-8818-817X
Elena Del FaveroDepartment of Medical Biotechnology and Translational Medicine, University of Milan, LITA, 20090 Segrate, Italy.ORCID 0000-0002-6584-1869
Caterina RicciDepartment of Medical Biotechnology and Translational Medicine, University of Milan, LITA, 20090 Segrate, Italy.ORCID 0000-0003-0573-4065
Laura CaliognaOrthopedy, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0000-0001-7545-7337
Barbara ViganiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Francesco Claudio PavesiOrthopedy, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Cesare PerottiImmunohaematology and Transfusion Service, Apheresis and Cell Therapy Unit, Fondazione IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.
Rui M A Domingues3B's Research Group, i3Bs-Research Institute on Biomaterials Biodegradables and Biomimetics, University of Minho, 4805-017 Guimarães, Portugal.
Manuela E Gomes3B's Research Group, i3Bs-Research Institute on Biomaterials Biodegradables and Biomimetics, University of Minho, 4805-017 Guimarães, Portugal.ORCID 0000-0002-2036-6291
Silvia RossiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-9511-3857
Giuseppina SandriDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-6766-9321
University of Pavia · ITPoliclinico San Matteo Fondazione · ITUniversity of Milan · ITUniversity of Minho · PT

Funding

European Commission 814607.
6 · The paper itself

Abstract

The enthesis is an extremely specific region, localized at the tendon-bone interface (TBI) and made of a hybrid connection of fibrocartilage with minerals. The direct type of enthesis tissue is commonly subjected to full laceration, due to the stiffness gradient between the soft tissues and hard bone, and this often reoccurs after surgical reconstruction. For this purpose, the present work aimed to design and develop a tubular scaffold based on pullulan (PU) and chitosan (CH) and intended to enhance enthesis repair. The scaffold was designed with a topographical gradient of nanofibers, from random to aligned, and hydroxyapatite (HAP) nanoparticles along the tubular length. In particular, one part of the tubular scaffold was characterized by a structure similar to bone hard tissue, with a random mineralized fiber arrangement; while the other part was characterized by aligned fibers, without HAP doping. The tubular shape of the scaffold was also designed to be extemporarily loaded with chondroitin sulfate (CS), a glycosaminoglycan effective in wound healing, before the surgery. Micro CT analysis revealed that the scaffold was characterized by a continuous gradient, without interruptions from one end to the other. The gradient of the fiber arrangement was observed using SEM analysis, and it was still possible to observe the gradient when the scaffold had been hydrated for 6 days. In vitro studies demonstrated that human adipose stem cells (hASC) were able to grow and differentiate onto the scaffold, expressing the typical ECM production for tendon in the aligned zone, or bone tissue in the random mineralized part. CS resulted in a synergistic effect, favoring cell adhesion/proliferation on the scaffold surface. These results suggest that this tubular scaffold loaded with CS could be a powerful tool to support enthesis repair upon surgery.

Indexed as

chitosanchondroitin sulfateelectrospun nanofibershydroxyapatite nanoparticlespullulanstem cells differentiationtendon tissue engineering

Identifiers

PMID36297586
PMCPMC9607365
OpenAlexW4304165616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.